9, 2024 — Scientists developed a highly promising gene therapy to treat glaucoma -- a ... Editing System Makes Gene-Sized Edits in Human Cells at Therapeutic Levels June 10, 2024 — Scientists ...

It’s been almost a year since the Food and Drug Administration approved the first genetic treatments for sickle cell disease.

Mice treated with the gene therapy remained cancer-free for at least 100 days and resisted cancer resurgence in a lab test.

Subsequently, it leads to deformed blood cells that adopt a crescent shape that looks like a sickle under a microscope. 2 CRISPR Cas9: Gene Therapy Play The rigid, distorted red blood cells cause ...

Kendric Cromer undergoing infusion gene therapy for his sickle cell disease at Children’s National Hospital in Washington last week.Credit...Kenny Holston/The New York Times Supported by By Gina ...

There's new hope for people with sickle cell disease which affects mainly African Americans. It's gene therapy research at ...

Advancements in cell and gene therapy have been driven by improved insights into the human immune system and a better ...

After raising $213 million in 2023—one of the year’s largest private biotech rounds—Tome Biosciences is making cuts. “Despite our clear scientific progress, investor sentiment has shifted ...

Scientists developed a highly promising gene therapy to treat glaucoma -- a debilitating eye condition that can lead to complete vision loss, and which affects around 80 million people worldwide. The ...

A new editorial was published in Oncoscience (Volume 11) on July 13, 2024, entitled, "Unveiling retrotransposon-derived DNA zip code for myeloma cell internalization." Gene therapy could ...